Beste Melek Atasoy, Gülşah Özden, Leyla Cinel, Dilek Gül, Ali Cemal Yumuşakhuylu, Zeynep Akdeniz Doğan
{"title":"口腔癌最坏侵袭模式对生存结果的影响:对辅助治疗和预后分层的影响。","authors":"Beste Melek Atasoy, Gülşah Özden, Leyla Cinel, Dilek Gül, Ali Cemal Yumuşakhuylu, Zeynep Akdeniz Doğan","doi":"10.1007/s12094-024-03788-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To examine the impact of the worst patterns of invasion (WPOI) on survival outcomes and possible implications for adjuvant treatment decisions in squamous cell oral cavity cancer patients.</p><p><strong>Methods: </strong>The loco-regional progression-free survival (LRPFS) and the distant metastasis-free survival (DMFS) were calculated for 162 patients. Univariate and multivariate analyses were done according to prognostic predictors of stage (early/T1-2 or N0; locally advanced /T3-4 or N +), grade, depth of invasion, WPOI, perineural (PNI), and lymphovascular (LVI) invasion and margin status. WPOI-V, PNI, and LVI were also analyzed for their positive status.</p><p><strong>Results: </strong>The median follow-up was 46 months (3-77 months). A total of 32 events, as loco-regional (n = 16), systemic progression (n = 14), and second primary lung cancer (n = 2) were observed. The presence of locally advanced disease, PNI or LVI, and WPOI-V were significantly worse prognostic factors for LRFS and DMFS. The 5-year LRPFS (74% vs. 92.8%, p = 0.001) and DMFS (74% vs. 94%, p < 0.0001) were significantly worse in patients with WPOI-V present. In multivariate analysis, WPOI-V patients had a worse prognosis for loco-regional relapse (p = 0.037) in early-stage cancer. There were no triple-positive patients in the early-stage group. LRRFS (90.4% vs. 59.7%, p < 0.0001) and DMFS (97% vs. 42.9%, p = 0.013) were significantly better in triple-negative patients compared to triple-positive patients.</p><p><strong>Conclusion: </strong>WPOI-V indicates a poor prognosis for locoregional progression and distant metastasis. Survival outcomes are significantly worse in triple-positive patients. These results need further evidence for adjuvant radiotherapy for early and systemic therapy for triple-positive locally advanced-stage patients.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"2651-2657"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of worst patterns of invasion on survival outcomes in oral cavity cancer: implications for adjuvant therapy and prognostic stratification.\",\"authors\":\"Beste Melek Atasoy, Gülşah Özden, Leyla Cinel, Dilek Gül, Ali Cemal Yumuşakhuylu, Zeynep Akdeniz Doğan\",\"doi\":\"10.1007/s12094-024-03788-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To examine the impact of the worst patterns of invasion (WPOI) on survival outcomes and possible implications for adjuvant treatment decisions in squamous cell oral cavity cancer patients.</p><p><strong>Methods: </strong>The loco-regional progression-free survival (LRPFS) and the distant metastasis-free survival (DMFS) were calculated for 162 patients. Univariate and multivariate analyses were done according to prognostic predictors of stage (early/T1-2 or N0; locally advanced /T3-4 or N +), grade, depth of invasion, WPOI, perineural (PNI), and lymphovascular (LVI) invasion and margin status. WPOI-V, PNI, and LVI were also analyzed for their positive status.</p><p><strong>Results: </strong>The median follow-up was 46 months (3-77 months). A total of 32 events, as loco-regional (n = 16), systemic progression (n = 14), and second primary lung cancer (n = 2) were observed. The presence of locally advanced disease, PNI or LVI, and WPOI-V were significantly worse prognostic factors for LRFS and DMFS. The 5-year LRPFS (74% vs. 92.8%, p = 0.001) and DMFS (74% vs. 94%, p < 0.0001) were significantly worse in patients with WPOI-V present. In multivariate analysis, WPOI-V patients had a worse prognosis for loco-regional relapse (p = 0.037) in early-stage cancer. There were no triple-positive patients in the early-stage group. LRRFS (90.4% vs. 59.7%, p < 0.0001) and DMFS (97% vs. 42.9%, p = 0.013) were significantly better in triple-negative patients compared to triple-positive patients.</p><p><strong>Conclusion: </strong>WPOI-V indicates a poor prognosis for locoregional progression and distant metastasis. Survival outcomes are significantly worse in triple-positive patients. These results need further evidence for adjuvant radiotherapy for early and systemic therapy for triple-positive locally advanced-stage patients.</p>\",\"PeriodicalId\":50685,\"journal\":{\"name\":\"Clinical & Translational Oncology\",\"volume\":\" \",\"pages\":\"2651-2657\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12094-024-03788-8\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-024-03788-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:探讨最坏侵袭模式(WPOI)对口腔鳞状细胞癌患者生存结局的影响,以及对辅助治疗决策的可能影响。方法:计算162例患者的局部-区域无进展生存期(LRPFS)和远端无转移生存期(DMFS)。根据预后预测因子(早期/T1-2或N0;局部进展/T3-4或N +),浸润程度,浸润深度,WPOI,神经周围(PNI)和淋巴血管(LVI)浸润和边缘状况。WPOI-V、PNI和LVI的阳性状态也进行了分析。结果:中位随访时间为46个月(3 ~ 77个月)。共观察到32个事件,包括局部-区域(n = 16)、全身进展(n = 14)和第二原发性肺癌(n = 2)。局部晚期疾病、PNI或LVI以及WPOI-V的存在是LRFS和DMFS的显著不良预后因素。5年LRPFS (74% vs. 92.8%, p = 0.001)和DMFS (74% vs. 94%, p)结论:WPOI-V提示局部进展和远处转移预后较差。三阳性患者的生存结果明显更差。这些结果需要进一步证明辅助放疗对三阳性局部晚期患者的早期和全身治疗。
The impact of worst patterns of invasion on survival outcomes in oral cavity cancer: implications for adjuvant therapy and prognostic stratification.
Purpose: To examine the impact of the worst patterns of invasion (WPOI) on survival outcomes and possible implications for adjuvant treatment decisions in squamous cell oral cavity cancer patients.
Methods: The loco-regional progression-free survival (LRPFS) and the distant metastasis-free survival (DMFS) were calculated for 162 patients. Univariate and multivariate analyses were done according to prognostic predictors of stage (early/T1-2 or N0; locally advanced /T3-4 or N +), grade, depth of invasion, WPOI, perineural (PNI), and lymphovascular (LVI) invasion and margin status. WPOI-V, PNI, and LVI were also analyzed for their positive status.
Results: The median follow-up was 46 months (3-77 months). A total of 32 events, as loco-regional (n = 16), systemic progression (n = 14), and second primary lung cancer (n = 2) were observed. The presence of locally advanced disease, PNI or LVI, and WPOI-V were significantly worse prognostic factors for LRFS and DMFS. The 5-year LRPFS (74% vs. 92.8%, p = 0.001) and DMFS (74% vs. 94%, p < 0.0001) were significantly worse in patients with WPOI-V present. In multivariate analysis, WPOI-V patients had a worse prognosis for loco-regional relapse (p = 0.037) in early-stage cancer. There were no triple-positive patients in the early-stage group. LRRFS (90.4% vs. 59.7%, p < 0.0001) and DMFS (97% vs. 42.9%, p = 0.013) were significantly better in triple-negative patients compared to triple-positive patients.
Conclusion: WPOI-V indicates a poor prognosis for locoregional progression and distant metastasis. Survival outcomes are significantly worse in triple-positive patients. These results need further evidence for adjuvant radiotherapy for early and systemic therapy for triple-positive locally advanced-stage patients.
期刊介绍:
Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.